Merit Med Sys Inc SEC Filings

Martha Goldberg Aronson, President and CEO of Merit Medical Systems, Inc. (MMSI), received a grant of 19,594 restricted stock units (RSUs) on 10/03/2025. The RSUs were granted at a reported price of $0 and represent the contingent right to receive one share of common stock per RSU upon vesting. The award vests in three equal annual installments on each of the first three anniversaries of the grant date, subject to continued service. After the grant, the reporting person is shown as beneficially owning 19,594 shares directly. The Form 4 was submitted via attorney-in-fact on 10/07/2025.

Aronson Martha Goldberg filed an Initial Statement of Beneficial Ownership (Form 3) for Merit Medical Systems Inc. The filing lists her address in South Jordan, UT and identifies her role as President and CEO. The date of the event requiring the statement is 10/03/2025.

The filing discloses no securities beneficially owned by the reporting person at the time of this Form 3. The document was signed by an attorney-in-fact, Brian G. Lloyd, on 10/07/2025.

Merit Medical Systems insider transactions: The company's President and CEO, Fred P. Lampropoulos, reported multiple stock option exercises and share surrenders on 08/29/2025. He exercised 159,151 options at a $55.73 exercise price and an additional 2,000 options at $55.73, resulting in 159,151 and 2,000 underlying shares respectively that were reported as acquired. He also surrendered 124,824 shares (for payroll taxes and option payment) and his spouse surrendered 1,454 shares for the same purpose; neither surrender involved open-market sales. Post-transactions, Mr. Lampropoulos beneficially owned 1,204,779 shares directly and certain additional shares indirectly through spouse and 401(k) holdings. Several outstanding option grants with various exercise prices and vesting schedules remain.

Lynne N. Ward, a director of Merit Medical Systems, Inc. (MMSI), executed option exercises and share sales on 08/22/2025. She exercised 3,000 non-qualified stock options with a $34.46 exercise price, resulting in 3,000 shares acquired. The same day she sold 3,000 shares in multiple transactions at a weighted average price of $88.56. After these transactions she beneficially owned 12,809 shares. The exercised options were originally granted with a $34.46 strike and become exercisable in equal annual installments of 33% commencing 08/28/2020; the exercised tranche had an expiration date of 08/28/2026.

Merit Medical Systems, Inc. (MMSI) Form 144 notice reports a proposed sale of 3,000 common shares valued at $265,683 to be sold through Morgan Stanley Smith Barney on NASDAQ on 08/22/2025. The filing states these shares were acquired the same day via stock option exercise and paid for in cash. The filer represents no undisclosed material adverse information about the issuer. The filing also lists a prior sale by Lynne Ward of 2,433 shares on 08/11/2025 for $206,535.91. Outstanding shares are listed as 59,219,117.

Lynne N. Ward, a director of Merit Medical Systems (MMSI), reported transactions dated 08/11/2025 on a Form 4. The filing shows the exercise of non-qualified stock options with an exercise price of $34.46 and an associated acquisition of 2,433 shares, and a contemporaneous sale of 2,433 shares at $84.8894.

Following the reported activity the form lists non-derivative beneficial ownership figures of 15,242 and 12,809 shares (as reported on separate lines) and indicates 3,000 derivative securities beneficially owned after the transactions, with 5,433 underlying common shares referenced for the options. The form is signed by an attorney-in-fact on 08/12/2025.

Merit Medical Systems (MMSI) submitted a Form 144 reporting a proposed sale of 2,433 common shares, with an aggregate market value of $206,535.91. The shares are listed on NASDAQ and the filing shows 59,219,117 shares outstanding for the issuer, indicating the position sold is a very small fraction of the company’s total shares. The securities were acquired and are being sold on 08/11/2025 as a result of a stock option exercise, and payment was in cash. The sale is to be executed through Morgan Stanley Smith Barney LLC, Executive Financial Services at 1 New York Plaza, New York.

The filing indicates Nothing to Report for securities sold in the past three months. The provided content does not identify the named seller or filer CIK in the visible text. The notice includes the standard attestation that the seller does not possess undisclosed material adverse information.